AGC Biologics published an article in Fierce Biotech explaining the team's approach to risk assessment and process improvement in quality control and raw materials.

Public source

Publisher name

Public post

At AGC Biologics, we are always looking for ways to improve processes, maximize technologies, and meet changing regulatory requirements. As a result of our commitment to…

Log in to read the full post

Company

AGC Biologics

We work side by side with our customers to improve patients’ lives by bringing new biopharmaceutical products to market.

Industry
Pharmaceutical Manufacturing
Location
Bothell, US
Company size
1,001–5,000 employees

About AGC Biologics

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners to provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cell therapies. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. Visit www.agcbio.com to learn more.

See more

Latest activity

14 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.